Company intelligence / Profile preview

Cyteph

Herston, Queensland, Australiacyteph.com ↗
Ownership
Private
Development stage
Other
01

Overview

Cyteph’s lead candidate, CYT-101, is an off-the-shelf HLA-matched CMV-specific T cell product currently in Phase 2 clinical development for astrocytoma and glioblastoma multiforme. Previous trials with autologous CMV-specific T cells showed safety and preliminary efficacy. The company’s proprietary Cyt-ATTAC platform aims to overcome challenges of solid tumor immunotherapy by using allogeneic donor-derived virus-specific killer T cells engineered with dual-targeting CARs[1][3][4].

Therapeutic areas
Oncology
Modalities
T cell therapyCAR T cell therapyAllogeneic cell therapyCell therapy (general)
Industry
Biotech
02

Drug pipeline

2 assets

CYT-AT2

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

QIMR Berghofer Medical Research InstituteAtara Biotherapeutics collaboration via key personnel at QIMR Berghofer

Beyond the preview

Go deeper on Cyteph.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyteph.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call